Εμφάνιση απλής εγγραφής

dc.creatorTagarakis, G. I.en
dc.creatorKarangelis, D.en
dc.creatorDaskalopoulos, M. E.en
dc.creatorTsilimingas, N. B.en
dc.date.accessioned2015-11-23T10:49:23Z
dc.date.available2015-11-23T10:49:23Z
dc.date.issued2010
dc.identifier10.2174/157489010793351926
dc.identifier.issn15748901
dc.identifier.urihttp://hdl.handle.net/11615/33536
dc.description.abstractMany researchers have until now united their efforts in the endeavor to discover new anticoagulants, which would be simpler to use and safer to administer, so that patients would avoid both thromboembolic events as well as life threatening episodes of bleeding. One of these agents, that is hereby presented along with patents, is dabigatran, which promises much for the future, despite the fact that time and the awaited results of ongoing trials will be necessary for its establishment as a first-line anticoagulant. More specifically, based on the major trials of RELY and RECOVER, we could state that dabigatran has presented satisfactory outcomes in terms of bleeding and prevention of venous thromboembolism. © 2010 Bentham Science Publishers Ltd.en
dc.source.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-78649982650&partnerID=40&md5=4ced39053fae22adedfeb9ecb0e89269
dc.subjectAnticoagulant &en
dc.subjectDabigatranen
dc.subjectPreventionen
dc.subjectacetylsalicylic aciden
dc.subjectamiodaroneen
dc.subjectclarithromycinen
dc.subjectcyclosporinen
dc.subjectdabigatran etexilateen
dc.subjectenoxaparinen
dc.subjectesomeprazoleen
dc.subjectgarlic extracten
dc.subjectginger extracten
dc.subjectibuprofenen
dc.subjectlansoprazoleen
dc.subjectmacrolideen
dc.subjectmetronidazoleen
dc.subjectmifepristoneen
dc.subjectnonsteroid antiinflammatory agenten
dc.subjectomeprazoleen
dc.subjectpantoprazoleen
dc.subjectpradaxen
dc.subjectprotamine sulfateen
dc.subjectquinidineen
dc.subjectrifampicinen
dc.subjectritonaviren
dc.subjectunclassified drugen
dc.subjectverapamilen
dc.subjectvitamin K groupen
dc.subjectwarfarinen
dc.subjectabdominal discomforten
dc.subjectabdominal painen
dc.subjectanticoagulationen
dc.subjectarticleen
dc.subjectbleedingen
dc.subjectclinical trialen
dc.subjectdiarrheaen
dc.subjectdrug indicationen
dc.subjectdrug safetyen
dc.subjectdyspepsiaen
dc.subjectfatigueen
dc.subjecthumanen
dc.subjectnauseaen
dc.subjectosteoporosisen
dc.subjectpatenten
dc.subjectpharmacodynamicsen
dc.subjectpriority journalen
dc.subjectskin diseaseen
dc.subjectvein thrombosisen
dc.subjectvenous thromboembolismen
dc.subjectvomitingen
dc.subjectAdministration, Oralen
dc.subjectAnticoagulantsen
dc.subjectBenzimidazolesen
dc.subjectbeta-Alanineen
dc.subjectHumansen
dc.titleDabigatran: The anticoagulant we have long expected?en
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής